International Journal of Obesity , 41(2), 177-187
Research progress of glucagon-like peptide-1 receptor agonists in cardiovascular complications of type 2 diabetes mellitus[J]
Svetlana Mojsov, a researcher at Rockefeller University whose work has been important in the characterization of GLP-1 and clarification of its role in glucose metabolism, explained in an interview with PNAS this September, Once we solve obesity, I think a lot of other disorders will be taken care of As for all the other pathophysiological states in which GLP-1-based drugs appear to be beneficial, I think it may have something to do with the drugs central role in regulating glucose metabolism. But lowering glucose isnt GLP-1s only job, though as Mojsov said, the relationship with glucose metabolism may be a crucial central part in the many related conditions it seems to treat
I need this for me, she said
If you are choosing glutathione, always opt for a liposomal liquid or capsule to ensure you are getting the most value for your investment
